Delivery Order SPE2DB24D2101-SPE2DB25FKNSH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 26, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic-corticosteroid medication used to treat ear infections. This firm fixed price delivery order has a ceiling value of $3,138.24 and is scheduled for completion by July 28, 2025. The award was made competitively without a set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,666.01 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,082.91 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL, a combination antibiotic-corticosteroid medication used to treat ear infections. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, utilized firm fixed price pricing under a non-set-aside, competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,647.96 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and anti-inflammatory medication used to treat ear infections. The contract, executed on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. Performance will be conducted at AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) with a ceiling value of $1,330.26. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,378.90 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside provisions and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $1,828.10 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL. This is a firm fixed-price, non-set-aside contract with performance completion scheduled for August 12, 2025, and fulfillment at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,097.53 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed price contract type. The award, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,670.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5 mL quantities. This is an unset-aside, competitively awarded contract with an ultimate completion date of July 22, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $2,100.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and corticosteroid medication used to treat ear infections. The contract, which was competitively awarded with no set-aside designation, was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. Performance will take place at AmerisourceBergen's corporate office location in...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNSHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,090.92 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) under a firm fixed-price contract type. The award was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle valued through December 2026 that enables comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor specializing in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability in competitively awarded delivery orders across multiple therapeutic domains, ranging from routine pharmaceutical supplies to specialized medical products. The Ciprofloxacin-Dexamethasone otic suspension being procured under this order is an antibiotic-corticosteroid combination medication commonly used in military and veteran healthcare settings for treating ear infections and related conditions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/20/25 |